BioCentury
ARTICLE | Company News

Admetric, SmithKline Beecham plc deal

November 6, 2000 8:00 AM UTC

The companies will develop and evaluate Admetric’s technology for profiling absorption, distribution, metabolism, excretion, and toxicology (ADMET) properties of drug candidates. Admetric will profile...